Collierville, TN, United States of America

M Chad Hollis

This inventor holds 7 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Crossroads Extremity Systems, LLC, Orthoalignment, LLC, Engage Medical Holdings, LLC. Active years: 2016-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: M Chad Hollis. Retrieved from https://idiyas.com/inventor/m-chad-hollis

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 

% Patents Active = 100.0

 

Average Co-Inventor Count = 1.9

ph-index = 3

Forward Citations = 47(Granted Patents)


Company Filing History:


Years Active: 2016-2026

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Inventor M Chad Hollis - Pioneering Innovations in Collierville

Introduction: M Chad Hollis is a distinguished inventor based in Collierville, TN, known for his groundbreaking contributions to various industries.

Latest Patents: Chad Hollis holds several patents in the fields of technology and healthcare, showcasing his versatility and ingenuity.

Career Highlights: Throughout his career, Chad Hollis has demonstrated a keen ability to identify gaps in the market and develop innovative solutions to address them. His passion for creating impactful inventions has led to significant advancements in the industry.

Collaborations: Chad Hollis has collaborated with leading companies and research institutions to bring his inventions to life. His collaborative spirit and dedication to excellence have earned him a reputation as a sought-after inventor in the field.

Conclusion: M Chad Hollis continues to push the boundaries of innovation, leaving a lasting impact on the industry and inspiring future generations of inventors.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…